期刊文献+

枳实消痞汤联合昂丹司琼防治恶性肿瘤化疗相关性恶心呕吐的疗效观察 被引量:2

下载PDF
导出
摘要 目的:观察枳实消痞汤联合昂丹司琼防治恶性肿瘤化疗相关性恶心呕吐临床效果及不良反应。方法:选取平顶山市第二人民医院恶性肿瘤化疗相关性恶心呕吐患者93例,以建档顺序随机分为对照组46例,观察组47例。对照组予昂丹司琼治疗,观察组予枳实消痞汤与昂丹司琼联合治疗,2组均持续治疗1周。结果:观察组总有效率为89.36%(95%CI=80.54%~98.18%),对照组为54.35%(95%CI=39.96%~68.74%),两组综合疗效比较(u=5.049 1,P<0.000 1);与对照组比较,观察组的不良反应发生率无显著性意义(χ~2=1.246 2,P>0.05)。结论:采用枳实消痞汤与昂丹司琼联合治疗恶性肿瘤化疗相关性恶心呕吐临床效果优于单纯应用昂丹司琼,其收益为OR=0.14(95%CI=0.05~0.42),NNT=3(95%CI=1.88~5.96),且两组总有效率的95%CI不重叠。
作者 爨国庆
出处 《山西中医》 2017年第10期34-35,共2页 Shanxi Journal of Traditional Chinese Medicine
  • 相关文献

参考文献7

二级参考文献43

  • 1张华,陈宝田,陈育尧,弓淑珍.枳实消痞汤颗粒毒性研究[J].中药药理与临床,2006,22(1):15-18. 被引量:3
  • 2Bijesh Raj Ghimire,林立平,郭颖,张力.同期化放疗在局部晚期鼻咽癌治疗中的作用:一项关于Ⅲ期随机对照试验的荟萃分析[J].循证医学,2007,7(3):158-166. 被引量:18
  • 3李东垣.兰室秘藏[M].北京:中医古籍出版社,1986:57
  • 4张天泽.中国常见恶性肿瘤诊治规范[M].2版.北京:北京医科大学中国协和医科大学联合出版社,1992:8.
  • 5Shirasaka T,Nakano K,Takechi T,Satake H,Uchida J,Fujioka A,Saito H,Okabe H,Oyama K,Takeda S,Unemi N,Fukushima M.Antitumor activity of 1 M tegafur-0.4 M 5-chloro-2,4-dihydroxypyridine-1 M potassium oxonate (S-1) against human colon carcinoma orthotopically implanted into nude rats. Cancer Research . 1996
  • 6Ingersoll GL, Wasilewski A, Haller M, et al. Effect of con- cord grape juice on chemotherapy-induced nausea and vom- iting:results of a pilot study [J]. Oncol Nurs Forum,2010, 37(2) :213-221.
  • 7Navari RM. Management of chemotherapy-induced nausea - and vomiting:focus on newer agents and new uses for older agents [J]. Drugs,2013,73 (3) :249-262.
  • 8Mori-Vogt S, Blazer M. Palonosetron for the prevention of - chemotherapy-induced nausea and vomiting[ J-. Expert Rev Anticaneer Ther,2013,13 ( 8 ) :919-936.
  • 9Craver C, Gayle J, Balu S, et al. Palonosetron versus other 5-HT3 receptor antagonists for prevention of chemotherapy- induced nau-sea and vomiting in patients with hematologic malignancies treated with emetogenic chemotherapy in a hospital outpatient setting in the United States [ J ]. J Med Econ,2011,14(3 ) :341-349.
  • 10Kim KI, Lee DE, Cho I, et al. Effectiveness of palonosetron versus other serotonin 5-HT3 receptor antagonists in triple antiemetic regimens during multiday highly emetogenic chemotherapy [ J]. Ann Pharmacother,2012,46 (12) : 1637- 1644.

共引文献69

同被引文献16

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部